TELCON RF PHARMACEUTICAL. Inc. (200230.KQ)

KRW 598.0

(0.0%)

Total Liabilities Summary of TELCON RF PHARMACEUTICAL. Inc.

  • TELCON RF PHARMACEUTICAL. Inc.'s latest annual total liabilities in 2023 was 35.47 Billion KRW , up 1.0% from previous year.
  • TELCON RF PHARMACEUTICAL. Inc.'s latest quarterly total liabilities in 2024 Q2 was 55.64 Billion KRW , up 58.06% from previous quarter.
  • TELCON RF PHARMACEUTICAL. Inc. reported annual total liabilities of 35.11 Billion KRW in 2022, down -42.82% from previous year.
  • TELCON RF PHARMACEUTICAL. Inc. reported annual total liabilities of 61.42 Billion KRW in 2021, down -34.36% from previous year.
  • TELCON RF PHARMACEUTICAL. Inc. reported quarterly total liabilities of 35.2 Billion KRW for 2024 Q1, down -0.74% from previous quarter.
  • TELCON RF PHARMACEUTICAL. Inc. reported quarterly total liabilities of 35.47 Billion KRW for 2023 FY, up 1.0% from previous quarter.

Annual Total Liabilities Chart of TELCON RF PHARMACEUTICAL. Inc. (2023 - 2012)

Historical Annual Total Liabilities of TELCON RF PHARMACEUTICAL. Inc. (2023 - 2012)

Year Total Liabilities Total Liabilities Growth
2023 35.47 Billion KRW 1.0%
2022 35.11 Billion KRW -42.82%
2021 61.42 Billion KRW -34.36%
2020 93.57 Billion KRW 471.92%
2019 16.36 Billion KRW -37.89%
2018 26.34 Billion KRW -64.94%
2017 75.14 Billion KRW 108.36%
2016 36.06 Billion KRW 766.46%
2015 4.16 Billion KRW -0.22%
2014 4.17 Billion KRW -55.08%
2013 9.28 Billion KRW 27.14%
2012 7.3 Billion KRW 0.0%

Peer Total Liabilities Comparison of TELCON RF PHARMACEUTICAL. Inc.

Name Total Liabilities Total Liabilities Difference
Taihan Fiber Optics Co., Ltd 158.78 Billion KRW 77.661%
Kmw Inc. 101.14 Billion KRW 64.933%
Samji Electronics Co., Ltd. 468.96 Billion KRW 92.436%
Intops Co., Ltd. 110.85 Billion KRW 68.003%
Ace Technologies Corp. 237.92 Billion KRW 85.092%
EM-Tech.CO., LTD. 161.93 Billion KRW 78.096%
Humax Co., Ltd. 584.53 Billion KRW 93.932%
Seojin System Co.,Ltd 1008.24 Billion KRW 96.482%
RFHIC Corporation 181.12 Billion KRW 80.416%
HFR, Inc. 92.2 Billion KRW 61.529%